Literature DB >> 7795356

Adverse drug reactions in a paediatric intensive care unit.

A M Gill1, H J Leach, J Hughes, C Barker, A J Nunn, I Choonara.   

Abstract

Adverse drug reactions (ADRs) were prospectively studied in critically ill infants and children. Seventy-six ADRs were reported in 63 patients out of a study group of 899 patients. The majority of the ADRs were mild (49), although 19 were of moderate severity and 8 were severe. Thirty-five ADRs required treatment or alteration in treatment. Midazolam, morphine, salbutamol, vecuronium, hydrocortisone and theophylline were the drugs most likely to cause an ADR. One-third of the ADRs were due to drugs used outside their product licence. The majority of the ADRs were reported by nurses (36) and pharmacists (30). We believe that it is possible to prospectively study drug toxicity in critically ill infants and children.

Entities:  

Mesh:

Year:  1995        PMID: 7795356     DOI: 10.1111/j.1651-2227.1995.tb13667.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  21 in total

Review 1.  Unlicensed and off-label drug use in children: implications for safety.

Authors:  Imti Choonara; Sharon Conroy
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

2.  Risk factors associated with adverse drug reactions in hospitalised children: international multicentre study.

Authors:  Asia N Rashed; Ian C K Wong; Noel Cranswick; Stephen Tomlin; Wolfgang Rascher; Antje Neubert
Journal:  Eur J Clin Pharmacol       Date:  2011-12-14       Impact factor: 2.953

3.  Are incorrectly used drugs more frequently involved in adverse drug reactions? A prospective study.

Authors:  A P Jonville-Béra; F Béra; E Autret-Leca
Journal:  Eur J Clin Pharmacol       Date:  2005-04-12       Impact factor: 2.953

4.  Acute drug prescribing to children on chronic antiepilepsy therapy and the potential for adverse drug interactions in primary care.

Authors:  Philipp H Novak; Suzie Ekins-Daukes; Colin R Simpson; Robert M Milne; Peter Helms; James S McLay
Journal:  Br J Clin Pharmacol       Date:  2005-06       Impact factor: 4.335

Review 5.  Off-label and unlicensed medicine use and adverse drug reactions in children: a narrative review of the literature.

Authors:  Jennifer Mason; Munir Pirmohamed; Tony Nunn
Journal:  Eur J Clin Pharmacol       Date:  2011-07-22       Impact factor: 2.953

6.  Adverse Drug Reactions in Children--International Surveillance and Evaluation (ADVISE): a multicentre cohort study.

Authors:  Asia N Rashed; Ian C K Wong; Noel Cranswick; Barbara Hefele; Stephen Tomlin; John Jackman; Kenneth Lee; Kam-Lun E Hon; Jeffrey Ong; Maisoon Ghaleb; Siew Siang Chua; Tea Ming Hui; Wolfgang Rascher; Antje Neubert
Journal:  Drug Saf       Date:  2012-06-01       Impact factor: 5.606

Review 7.  The medico-legal aspects of prescribing vitamin D.

Authors:  John S Davies; Chris D Poole; Peter Feldschreiber
Journal:  Br J Clin Pharmacol       Date:  2014-12       Impact factor: 4.335

Review 8.  Incidence of adverse drug reactions in paediatric in/out-patients: a systematic review and meta-analysis of prospective studies.

Authors:  P Impicciatore; I Choonara; A Clarkson; D Provasi; C Pandolfini; M Bonati
Journal:  Br J Clin Pharmacol       Date:  2001-07       Impact factor: 4.335

9.  Adverse drug reactions and off-label drug use in paediatric outpatients.

Authors:  Benjamin Horen; Jean-Louis Montastruc; Maryse Lapeyre-Mestre
Journal:  Br J Clin Pharmacol       Date:  2002-12       Impact factor: 4.335

10.  Off-label, off-limits? Parental awareness and attitudes towards off-label use in paediatrics.

Authors:  Christian Lenk; Philipp Koch; Hildegard Zappel; Claudia Wiesemann
Journal:  Eur J Pediatr       Date:  2009-03-11       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.